Harbor Capital Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$866K Buy
33,653
+1,790
+6% +$41.5K 0.06% 395
2026
Q1
$655K Sell
31,863
-9,898
-24% -$223K 0.05% 425
2025
Q4
$990K Buy
41,761
+4,955
+13% +$121K 0.08% 331
2025
Q3
$916K Sell
36,806
-277
-0.7% -$5.96K 0.07% 341
2025
Q2
$853K Buy
37,083
+5,574
+18% +$129K 0.04% 459
2025
Q1
$707K Buy
31,509
+6,804
+28% +$158K 0.03% 481
2024
Q4
$483K Sell
24,705
-3,246
-12% -$64.3K 0.02% 562
2024
Q3
$509K Sell
27,951
-1,983
-7% -$37.8K 0.02% 571
2024
Q2
$520K Sell
29,934
-22,530
-43% -$399K 0.04% 524
2024
Q1
$1.03M Buy
+52,464
New +$1.11M 0.13% 206

Other funds holding PRVA

Harbor Capital Advisors's PRVA Position: Q2 2026 in Review

Harbor Capital Advisors increased its Privia Health (PRVA) stake by 5.6% in Q2 2026, buying an estimated $41.5K and bringing the position to 33,653 shares worth $866K. The position accounts for 0.06% of the portfolio, ranked #395.

Harbor Capital Advisors first reported a position in PRVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.03M in Q1 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Harbor Capital Advisors held 33,653 shares of Privia Health worth $866K as of Q2 2026.
  • Harbor Capital Advisors bought 1,790 Privia Health shares in Q2 2026, an estimated $41.5K.
  • Privia Health made up 0.06% of Harbor Capital Advisors's portfolio in Q2 2026, its #395 holding.
  • Harbor Capital Advisors first reported a position in Privia Health in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Privia Health position peaked at $1.03M in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.